VYNE Therapeutics Inc.
A biopharmaceutical company focused on developing proprietary, innovative and differentiated therapeutics for the treatment of immune-inflammatory diseases. The company is developing a treatment for mild to moderate atopic dermatitis. The company is also developing BET inhibitor product candidates for a range of immune-inflammatory diseases, including dermatological conditions. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | New Jersey |
Employees | 10 |
Founded | 2003 |
Financials | |
|---|---|
Market Capitalization | 31.09M |
Revenue | 0.42M |
Operating Income | -30.76M |
Operating Margin | -7272.81% |
Net Income | -29.08M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4193 / 5373 |
Sector : Healthcare | 600 / 1144 |
Industry : Biotechnology | 248 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4774 / 5565 |
Sector : Healthcare | 888 / 1182 |
Industry : Biotechnology | 490 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4030 / 5436 |
Sector : Healthcare | 570 / 1164 |
Industry : Biotechnology | 243 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4992 / 5330 |
Sector : Healthcare | 1044 / 1174 |
Industry : Biotechnology | 562 / 667 |